Ticker Hub
INTS — AI Analysis & Sentiment
3 recent AI-generated analyses for INTS. Sentiment and confidence insights updated continuously.
Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Intensity Therapeutics' preliminary clinical data is positive, but severe financial constraints and reliance on continuous dilution via an ATM faci...
May 7, 2026Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
Preliminary Phase 2 data for INT230-6 shows promising efficacy and safety in triple-negative breast cancer, leading to resumed enrollment and a pot...
Mar 12, 2026Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement
Intensity Therapeutics regained compliance with Nasdaq's minimum bid price requirement, removing the immediate threat of delisting. This is crucial...
Mar 6, 2026